The Ellie Helton, Lisa Colagrossi, Kristen Shafer Englert, Teresa Anne Lawrence, and Jennifer Sedney Focused Research Act authorizes dedicated federal funding to increase research on unruptured intracranial aneurysms through the NINDS.
Richard Blumenthal
Senator
CT
The Ellie Helton, Lisa Colagrossi, Kristen Shafer Englert, Teresa Anne Lawrence, and Jennifer Sedney Focused Research Act, or "Ellies Law," addresses the significant public health threat posed by brain aneurysms. This legislation authorizes $10 million annually from fiscal years 2026 through 2030 specifically for the National Institute of Neurological Disorders and Stroke (NINDS). These funds are dedicated to supporting and expanding research on unruptured intracranial aneurysms, ensuring diverse patient representation in studies. The funding is intended to supplement, not replace, existing research budgets.
This legislation, officially named the Ellie Helton, Lisa Colagrossi, Kristen Shafer Englert, Teresa Anne Lawrence, and Jennifer Sedney Focused Research Act (or “Ellie’s Law”), authorizes a serious funding boost for research into unruptured brain aneurysms. Starting in fiscal year 2026 and running through 2030, the bill authorizes Congress to set aside $10 million annually for the National Institute of Neurological Disorders and Stroke (NINDS). This money is laser-focused on finding better ways to detect and manage those ticking time bombs before they rupture.
To understand why this bill matters, you have to look at the numbers: about 6.8 million people in the U.S. are walking around with an unruptured brain aneurysm, and most don't know it. When one ruptures, it’s fatal half the time, and survivors often face permanent disability, costing families an estimated $144,000 out-of-pocket on average. The bill points out that despite this massive cost and risk, the federal government currently spends less than $3 per affected person on research each year.
Section 3 of the bill is the engine, authorizing $10 million yearly for five years (FY 2026–2030) for NINDS. This isn't just a suggestion; the bill has strict rules about how this money must be used. Crucially, the funds must supplement, not supplant existing research budgets. Think of it like this: the government can't just take the $10 million and use it to cover what they were already supposed to pay for; it has to be a genuine addition to current funding. This ensures the money actually translates into new, expanded research efforts.
One of the most important provisions requires that the research funded under this Act must include diverse patient populations, specifically across age, sex, and race. This is vital because, as the bill notes, women are more susceptible to developing aneurysms, and African American and Hispanic individuals are nearly twice as likely to experience a rupture. By mandating diversity, the bill aims to close diagnostic and treatment gaps that currently leave certain populations at higher risk, ensuring that the research benefits everyone equally.
What does this mean for you? If this funding is appropriated, it means better tools for doctors to spot these issues early, potentially saving lives and preventing catastrophic medical debt. For example, a new diagnostic tool developed through this research could mean that someone like Kristen Shafer Englert, who was sent home from the ER with symptoms, might instead get a scan that catches the aneurysm before it’s too late. The funds remain available until September 30, 2033, which gives researchers a long runway to tackle this complex problem and deliver tangible results that could change the standard of care for millions.